ZNF32-AS2

Across TCGA pan-cancer cohorts, ZNF32-AS2 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated ZNF32-AS2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ZNF32-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF32-AS2 expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.

KIRC, UCS, and HNSC are the cancer types where ZNF32-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.555	0.719	<.001	83	view →
UCS	DFS	Median	IV	0.952	0.367	.001	64	view →
HNSC	OS	Tertile	II,III,IV	0.490	0.310	.002	61	view →
BLCA	OS	Median	All	0.527	0.353	.001	60	view →
LIHC	DFS	Quartile	All	0.392	0.587	<.001	44	view →
STAD	DFS	Median	IV	0.121	0.669	.002	37	view →
SKCM	DFS	Quartile	All	0.236	0.120	.001	36	view →
PRAD	DFS	Quartile	All	0.692	0.852	.002	34	view →
CESC	DFS	Median	All	0.781	0.858	.017	28	view →
READ	OS	Median	All	0.837	0.292	.002	26	view →
UVM	DFS	Median	III,IV	0.208	0.740	.006	24	view →
ACC	DFS	Tertile	All	0.407	0.781	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

ZNF32-AS2–KIRC (DFS)

Open the KIRC breakdown →